Delivery Order SPE2DB20D9354-SPE2DB25FX7X4
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 28, 2025, by the Defense Logistics Agency (DLA) for the supply of Jakafi 15 mg tablets (60 count). This $24.0K firm fixed-price delivery order, which was completed on July 29, 2025, carries no set-aside designation and represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 for Jakafi 10 mg tablets (60-count units) by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This delivery order was issued without a set-aside designation, and performance will take place at the vendor's Park Ridge, Illinois facility. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total contract value of $499,999,999 through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency on July 21, 2025, for the supply of Jakafi 10 mg tablets (60-count packages). The contract utilizes a firm fixed-price structure with no set-aside designation and carries an ultimate completion date of July 22, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48.6K on August 14, 2025, for the supply of Jakafi 5 mg tablets (60-count units) to support federal medical supply needs. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents execution under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on August 12, 2025, for the supply of Jakafi 10 mg tablets (60-count). This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 13, 2025. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a $60.6 million firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 60-count bottles of Jakafi 10 mg tablets, with an ultimate completion date of July 31, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 31, 2025, by the Defense Logistics Agency for the supply of Jakafi 10 mg tablets (60-count unit). This firm fixed-price delivery order, valued at $24,231.30, represents a single shipment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The contract includes no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc. on August 4, 2025, for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility. This award utilizes a firm fixed-price contract structure with no set-aside designation, allowing the vendor to compete directly in the...
- SPE2DB20D9354Indefinite Delivery Contract
- SPE2DB20D9354-SPE2DB25FX7X4Delivery Order
The Defense Logistics Agency awarded a $24,231.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 10 mg on August 22, 2025, with an ultimate completion date of August 25, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. Jakafi (ruxolitinib) is a prescription medication used in the treatment of myeloproliferative neoplasms and other blood disorders, representing the type of specialty pharmaceutical products that DMS Pharmaceutical Group routinely supplies to Department of Defense healthcare sites. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently secured contracts for an extensive portfolio of medical products including prescription medications, biologics, vaccines, and specialty treatments to military and federal healthcare facilities nationwide, leveraging its status as a woman-owned small business to compete effectively in federal procurement markets.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.2k | 8/22/25 |